Loading…
← CockpitCompetitor Analysis › 300758.SZ Anshan Hifichem Co., Ltd. Class AOpen in the cockpit ↗

Anshan Hifichem Co., Ltd. Class A300758.SZCompetitor analysis, valuation and peers

China · CNY·Materials›Chemicals: Specialty
Momentum strong 74
Mkt cap
$631M
US dollars, full cap
Free float
69%
of shares outstanding
$/day
$11.4M
20-day average traded
Fwd P/E
46.4×
forward earnings
ROIC−WACC
-2.8 pp
WACC 10.4%
Hurdle
+8 pp
Req g minus delivered
Next earnings
161 days
28 Apr 2027
Close · CNYCN¥10.74
1D+1.7%
1W-0.6%
1M-4.6%
3M-0.7%
6M-26.2%
YTD-15.4%
1Y-23.8%
ATR %4.5%
52w lowhigh50.3% off high

What Anshan Hifichem does

Employees: 2,241

Anshan Hifichem at a glance

Size Anshan Hifichem (300758.SZ) is a China Materials company (Chemicals: Specialty) with a market value of $631M, the 3128th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥10.74 on 18 Nov 2026.

Performance Over six months the shares fell 26.2%, against -21.2% for the median peer and -20.0% for the China market (cap-weighted) — 10th lowest of 20 in its peer set.

Growth Revenue grew 11.5% over the last twelve months (peer median +11.2%); the operating margin is 9.3% (peer median 6.9%).

Valuation It trades at 46.4× forward earnings against a peer median of 26.4× (3rd most expensive of 10).

Price implies For today's price to make sense, revenue must grow about 16% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is +8 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 2.8 points below its cost of capital (10.4% WACC).

Next results Next results expected around 28 Apr 2027 (exchange calendar; dates can move).

Relative performance

8010021 May 202621 Aug 202618 Nov 2026300758.SZ 76Peer median 74
Six months, rebased to 100: Anshan Hifichem against the median of its 20 peers (local-currency closes).

Anshan Hifichem financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥1.70BCN¥1.49BCN¥1.56BCN¥1.21BCN¥1.20B
Revenue growth—-5%+29%+1%—
Gross profitCN¥642MCN¥420MCN¥479MCN¥274MCN¥281M
EBITDAn/aCN¥304MCN¥358MCN¥185MCN¥141M
Net incomeCN¥83.5MCN¥61.2MCN¥125MCN¥11.0M-CN¥2.79M
Free cash flowCN¥106M-CN¥87.3MCN¥69.1M-CN¥161M-CN¥95.0M
Capital expenditureCN¥55.8MCN¥162MCN¥75.8MCN¥165MCN¥192M
Total debtCN¥1.22BCN¥1.32BCN¥1.19BCN¥1.06BCN¥1.08B

Quarterly statements and history in the cockpit →

Anshan Hifichem competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%+100%+150%-20%-10%0%+10%40284770DQ301076688733WAGA170930155730072741160040008014603217301349002455300478301419300758.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Anshan Hifichem is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%20×40×40284770301076688733300727004000603217BALAMINES301349300758.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Anshan Hifichem is the large dot.

Capital: growth delivered against growth the price implies

-20%0%+20%-20%0%20%40284770301076170930072741160040008014300478000210300758.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Anshan Hifichem is the large dot.

Anshan Hifichem competitors and peer comparison

How Anshan Hifichem compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Anshan Hifichem against its 20 peers (data as of 18 Nov 2026)
Measure300758.SZPeer medianRank in peer set
1-month return-4.6%-7.3%8th highest of 21
6-month return-26.2%-21.2%10th lowest of 20
Distance from 52-week high-50.3%-36.5%8th lowest of 21
Revenue growth (TTM)+11.5%+11.2%11th highest of 21
Operating margin9.3%6.9%8th highest of 20
Forward P/E46.4×26.4×3rd most expensive of 10
Growth the price implies (Req g, 7 yrs)16.0%1.8%5th most demanding of 12
Growth delivered (Del g)+8.2%+7.8%6th highest of 11
Hurdle (Req g minus delivered)+7.9 pp-8.9 pp4th most demanding of 11
ROIC minus cost of capital-2.8 pp-1.6 pp7th lowest of 19

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Anshan Hifichem 300758.SZChina$631M-26%+11%9%46.4×16.0%+8.2%
Ishihara Sangyo Kaisha 4028.TJapan$631M-7%+3%10%11.6×2.1%+8.8%
Allied Supreme 4770.TWTaiwan$628M+22%-5%21%13.0×1.3%+12.4%
Daqo New Energy Corp Sponsored ADR DQUnited States$639M-46%-21%-70%n/an/an/a
Sino-High (China) 301076.SZChina$640M-43%+10%13%49.6×34.0%+9.1%
Anhui Estone Materials Technology 688733.SSChina$622M-43%+52%-2%47.7×n/an/a
Waga Energy WAGA.PAFrance$642M-3%+7%-20%n/an/an/a
Formosan Union Chemical 1709.TWTaiwan$619M+159%+14%41%n/a-17.9%+1.2%
Cytech 301557.SZChina$619M-1%+13%7%n/an/an/a
Ningbo Runhe High-Tech Materials 300727.SZChina$648M-38%+18%5%39.7×32.2%+14.6%
Hangzhou Grascent 301688.SZChina$613Mn/a+12%n/an/a42.9%n/a
Dainichiseika Color & Chemicals Mfg.Co 4116.TJapan$610M+23%+5%8%n/a1.8%-2.1%
LOTTE Fine Chem 004000.KSSouth Korea$610M-45%+18%7%4.3×-20.1%+6.8%
Chori 8014.TJapan$657M0%+3%4%n/a-11.9%+6.7%
Yuanli Chemical 603217.SSChina$657M-34%+19%9%17.8×n/an/a
Balaji Amines BALAMINES.NSIndia$658M+11%+21%19%34.2×n/an/a
Liaoning Xinde New Material Technology 301349.SZChina$660M-34%+63%7%26.4×n/an/a
Jiangsu Baichuan High-Tech New Materials 002455.SZChina$604M-43%+9%1%n/an/an/a
Hangzhou Gaoxin Materials Technology 300478.SZChina$600M-21%-21%-9%n/a29.9%-0.9%
DL 000210.KSSouth Korea$666M-36%+5%10%n/a-7.5%+27.7%
Shanghai Allied Industrial 301419.SZChina$666M-4%+19%14%n/an/an/a

Questions

Which companies are Anshan Hifichem's closest peers?
The cockpit's peer set: Ishihara Sangyo Kaisha (4028.T), Allied Supreme (4770.TW), Daqo New Energy Corp Sponsored ADR (DQ), Sino-High (China) (301076.SZ), Anhui Estone Materials Technology (688733.SS), Waga Energy (WAGA.PA), Formosan Union Chemical (1709.TW), Cytech (301557.SZ).
Is Anshan Hifichem expensive compared with its peers?
On forward p/e it trades at 46.4× against a peer median of 26.4×, 3rd most expensive of 10 in its peer set. For today's price to make sense, revenue must grow about 16% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is +8 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Anshan Hifichem stock performed?
Over six months to 18 Nov 2026 the shares returned -26.2% against -21.2% for the median peer; over one year -23.8%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.